{
    "moduleId": "module_19",
    "moduleTitle": "Module 19: Research & Evidence",
    "passingScore": 80,
    "questions": [
        {
            "id": "q19_1",
            "question": "In the hierarchy of evidence for microbiome science, which of the following is considered the most robust for determining clinical efficacy?",
            "options": [
                "Systematic reviews and meta-analyses of RCTs",
                "Case-control observational studies",
                "In vitro (cell culture) mechanistic studies",
                "Animal models (e.g., germ-free mice)"
            ],
            "correctAnswer": 0,
            "explanation": "Systematic reviews and meta-analyses sit at the top of the evidence hierarchy as they synthesize data from multiple high-quality randomized controlled trials (RCTs) to provide a more definitive conclusion."
        },
        {
            "id": "q19_2",
            "question": "When critically appraising a study, why is it dangerous to rely solely on a p-value of <0.05?",
            "options": [
                "It indicates the study was not double-blinded",
                "Statistical significance does not always equate to clinical relevance or effect size",
                "A p-value of 0.05 means there is a 50% chance the results are false",
                "P-values are only used in animal studies, not human trials"
            ],
            "correctAnswer": 1,
            "explanation": "A result can be statistically significant (p < 0.05) but have such a small effect size that it makes no real-world difference to the clientâ€™s health or symptoms."
        },
        {
            "id": "q19_3",
            "question": "Which factor contributes most significantly to the 'Translational Gap' when applying findings from mouse microbiome studies to humans?",
            "options": [
                "Mice and humans share 99% of the same gut bacterial species",
                "Mice are coprophagic (eat their own feces), which constantly re-seeds their microbiome",
                "The human cecum is proportionally larger and more functional than the mouse cecum",
                "Mice in labs have higher genetic diversity than human populations"
            ],
            "correctAnswer": 1,
            "explanation": "Coprophagy in mice, along with differences in anatomy (human cecum is smaller/vestigial compared to mice) and the controlled lab environment, makes it difficult to replicate findings in humans living complex lives."
        },
        {
            "id": "q19_4",
            "question": "What is the primary advantage of Shotgun Metagenomic Sequencing over 16S rRNA sequencing?",
            "options": [
                "It is significantly cheaper and faster to process",
                "It only identifies bacteria, whereas 16S identifies viruses and fungi",
                "It provides functional data (what the microbes are doing) and species-level resolution",
                "It requires a much smaller stool sample size"
            ],
            "correctAnswer": 2,
            "explanation": "While 16S rRNA is limited to taxonomic identification (usually at the genus level), Shotgun Metagenomics sequences all genomic DNA, allowing for species/strain identification and functional gene profiling."
        },
        {
            "id": "q19_5",
            "question": "Research indicates that the placebo response in Irritable Bowel Syndrome (IBS) clinical trials is approximately:",
            "options": [
                "Under 5%",
                "Between 10% and 15%",
                "Between 30% and 40%",
                "Over 75%"
            ],
            "correctAnswer": 2,
            "explanation": "IBS trials are known for a high placebo response rate, often cited between 30-40%, which underscores the importance of using placebo-controlled designs in gut health research."
        },
        {
            "id": "q19_6",
            "question": "A meta-analysis concludes that 'probiotics are ineffective for UC.' What is the most likely methodological flaw in this conclusion based on Lesson 6?",
            "options": [
                "The researchers used too many participants",
                "The study 'pooled' different strains together rather than analyzing strain-specific effects",
                "The researchers only looked at peer-reviewed journals",
                "The study was conducted over a period of 12 months"
            ],
            "correctAnswer": 1,
            "explanation": "Probiotic effects are strain-specific. Pooling diverse strains into a single analysis can mask the efficacy of specific strains (like E. coli Nissle 1917) by averaging them with ineffective ones."
        },
        {
            "id": "q19_7",
            "question": "According to the ISAPP consensus, what defines a 'Postbiotic'?",
            "options": [
                "Live microorganisms that confer a health benefit",
                "A substrate that is selectively utilized by host microorganisms",
                "A preparation of inanimate microorganisms and/or their components that confers a health benefit",
                "The fiber found in chicory root and Jerusalem artichoke"
            ],
            "correctAnswer": 2,
            "explanation": "Postbiotics are defined as inanimate (dead) microorganisms or their components (like cell wall fragments or metabolites) that still provide a documented health benefit to the host."
        },
        {
            "id": "q19_8",
            "question": "What is the mechanism of action for Phage Therapy in microbiome modulation?",
            "options": [
                "Providing a broad-spectrum antibiotic effect to clear all gut bacteria",
                "Viruses that specifically target and lyse (destroy) pathogenic bacterial strains",
                "Fermentable fibers that feed beneficial Bifidobacteria",
                "Short-chain fatty acids that lower the pH of the colon"
            ],
            "correctAnswer": 1,
            "explanation": "Bacteriophages are viruses that target specific bacteria. This allows for 'precision' modulation, killing pathogens like E. coli or C. diff without damaging the beneficial commensal flora."
        },
        {
            "id": "q19_9",
            "question": "A client brings you a study showing a new supplement 'cured gut dysbiosis' in 10 people. As a coach, you identify this as which type of limitation?",
            "options": [
                "Lack of biological plausibility",
                "Selection bias in recruitment",
                "Small sample size (n=10) and lack of a control group",
                "The Nocebo effect"
            ],
            "correctAnswer": 2,
            "explanation": "A sample size of 10 is too small to generalize to the public, and without a control group, it is impossible to determine if the 'cure' was due to the supplement or the placebo effect/natural recovery."
        },
        {
            "id": "q19_10",
            "question": "Which of the following actions is within the legal and ethical scope of practice for a Gut Health Coach?",
            "options": [
                "Diagnosing SIBO based on a client's breath test results",
                "Telling a client to stop taking their prescribed immunosuppressants",
                "Interpreting research to help a client discuss evidence-based probiotic strains with their doctor",
                "Prescribing a specific dose of a pharmaceutical antifungal"
            ],
            "correctAnswer": 2,
            "explanation": "Coaches should not diagnose or prescribe. Their role is to educate the client and empower them to have informed conversations with their licensed medical providers."
        }
    ]
}